Connect with us

Health

Post-Vax Clot Case Supports Angiomax Use – MedPage Today

This might be a good non-heparin alternative, docs say

Published

on

Article feature image

Bivalirudin (Angiomax) worked for one of the very rare cases of blood clots with low platelets after vaccination against COVID-19, researchers reported.
The 40-year-old woman presented with a headache on the same day that the CDC and FDA hit pause on use of the Johnson & Johnson vaccine over risk of what’s being dubbed vaccine-induced thrombotic thrombocytopenia (VITT) or thrombosis with thrombocytopenia syndrome (TTS).
She developed a headache, sinus pressure, myalgias, and sore throat with tonsillar…

Click here to view the original article.

Continue Reading
Advertisement

You might also like ...

Article feature image
These twins were like two peas in a pod — except when Covid-19 struck – STLtoday.com
Article feature image
Third wave of COVID-19 could be dangerous for kids: Pediatrician suggests steps to safeguard them – TheHealthSite